Indicator categories | Regulatory systems | Marketing authorisation | Vigilance | Market surveillance and control | Licensing | Regulatory inspections | Laboratory testing | Clinical trials | Lot release | Total |
Leadership and crisis management | 5 | 5 | ||||||||
Legal provisions, regulations, and guidelines | 9 | 13 | 7 | 7 | 5 | 5 | 2 | 11 | 2 | 61 |
Monitoring progress and assessing impact | 2 | 2 | 2 | 3 | 2 | 5 | 4 | 4 | 4 | 28 |
Organisation and governance | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 20 |
Policy and strategic planning | 5 | 7 | 12 | |||||||
Quality and risk management system | 14 | 14 | ||||||||
Regulatory process | 10 | 8 | 8 | 4 | 6 | 6 | 7 | 3 | 52 | |
Resources | 12 | 4 | 4 | 4 | 4 | 4 | 6 | 4 | 4 | 46 |
Transparency, accountability and communication | 9 | 4 | 3 | 3 | 2 | 4 | 1 | 2 | 2 | 30 |
Total | 60 | 35 | 26 | 27 | 19 | 26 | 28 | 30 | 17 | 268 |